Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Clinical trial NCT04997993 · RECRUITING
Trial details
- NCT number
- NCT04997993
- Sponsor
- Deborah Doroshow
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2027-07-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.